Medical Devices Latin America

Latin America Genetic Testing Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Latin America Genetic Testing Market Industry Trends and Forecast to 2034: Segmented by (Type, Technology, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Latin America · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $914.5 Mn Placeholder estimate
Estimate 2025 $1.02 Bn 4.6% of the global market
Projected 2034 $2.74 Bn 168.5% Adds $1.72 Bn over 9 forecast years
CAGR 2025–2034 11.6% Faster than 67% of 193 Medical Devices markets here
Key players 6 +1
  • Latin America is 4.6% of the global market.
  • Among regions, the largest is North America at $12.35 Bn.
  • Fastest growing: Africa at 12.7% a year.
  • Latin America ranks 4th of 6 by size among regions.

Market size projection

Latin America

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.72 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Genetic Testing Market market size by year, Latin America
YearMarket sizeChange that yearSince 2025
2024 (estimate) $914.5 Mn — —
2025 (base) $1.02 Bn +$106.1 Mn —
2026 (forecast) $1.14 Bn +$118.4 Mn +11.6%
2027 (forecast) $1.27 Bn +$132.1 Mn +24.5%
2028 (forecast) $1.42 Bn +$147.4 Mn +39%
2029 (forecast) $1.58 Bn +$164.5 Mn +55.1%
2030 (forecast) $1.77 Bn +$183.6 Mn +73.1%
2031 (forecast) $1.97 Bn +$204.9 Mn +93.2%
2032 (forecast) $2.20 Bn +$228.7 Mn +115.6%
2033 (forecast) $2.46 Bn +$255.2 Mn +140.6%
2034 (forecast) $2.74 Bn +$284.8 Mn +168.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Latin America Genetic Testing Market Analysis at a glance
Market size, 2025$1.02 Bn placeholder estimate
Forecast, 2034$2.74 Bn placeholder estimate
Growth (CAGR), 2025–203411.6% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType, technology and end user (see all)
Key playersMyriad Genetics, Inc., Illumina, Inc., Natera, Invitae, Quest Diagnostics and 1 more (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Latin America Genetic Testing Market Analysis Executive Summary

Genetic testing reads a person's DNA to find inherited conditions, cancer risk, drug response and family links.

Key segments of the genetic testing market include type (Predictive Testing, Carrier Testing and Diagnostic Testing) and technology (PCR, Sequencing and Microarrays).

Bar chart: Latin America Genetic Testing market size, 2024–2034, placeholder estimates. $914.5 Mn in 2024, $1.02 Bn in 2025 and $2.74 Bn in 2034, 11.6% CAGR.
Latin America Genetic Testing market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Latin America Genetic Testing Market Dynamics

Market Growth Drivers

Falling costs of testing, more demand for precision medicine and steady research spending by drug makers and labs are driving the genetic testing market.

Opportunity

Automation, smaller and cheaper instruments and growth in cancer and genetic testing give the genetic testing market room to grow.

Market Restraints

Costly instruments, a shortage of skilled lab staff and uneven payment for new tests hold back the genetic testing market.

Competitive Landscape for Genetic Testing Market in Latin America

The genetic testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Genetic Testing Market in Latin America

Genetic Testing in Latin America: rules and payment

In some of the countries we cover here, medical devices are regulated by ANVISA (Brazil)⁠[1], ARCSA (Ecuador)⁠[2], COFEPRIS (Mexico)⁠[3], ANMAT (Argentina)⁠[4], INVIMA (Colombia)⁠[5] and ISP (Chile)⁠[6]. How care is paid for in some of these countries: the SUS (Brazil)⁠[7]; public care and IESS (Ecuador)⁠[8]; IMSS, ISSSTE and IMSS-Bienestar (Mexico)⁠[9]; public care, obras sociales and prepaid plans (Argentina)⁠[10]; social health insurance (EPS) (Colombia)⁠[11]; and FONASA and ISAPREs (Chile)⁠[12].

[1] ANVISA. Checked 14 Nov 2026.

[2] ARCSA. Checked 14 Nov 2026.

[3] COFEPRIS. Checked 14 Nov 2026.

[4] ANMAT. Checked 19 Nov 2026.

[5] INVIMA. Checked 19 Nov 2026.

[6] Institute of Public Health of Chile (ISP). Checked 19 Nov 2026.

[7] CONITEC. Checked 14 Nov 2026.

[8] Ministry of Public Health of Ecuador. Checked 14 Nov 2026.

[9] Mexican Social Security Institute (IMSS). Checked 14 Nov 2026.

[10] Superintendence of Health Services (SSSalud). Checked 19 Nov 2026.

[11] Ministry of Health and Social Protection. Checked 19 Nov 2026.

[12] FONASA. Checked 19 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how genetic testing products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Latin America.

Public data, with sources

Genetic Testing in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Genetic Testing market in Latin America?
Placeholder estimate: about $1.02 Bn in 2025, rising to about $2.74 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Genetic Testing market in Latin America growing?
Placeholder estimate: about 11.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Genetic Testing market report cover?
The report splits the market by type (Predictive Testing, Carrier Testing, Diagnostic Testing, Newborn Screening and more), technology (PCR, Sequencing, Microarrays) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Genetic Testing market?
Key players include Myriad Genetics, Inc., Illumina, Inc., Natera, Invitae, Quest Diagnostics and Labcorp.
What is driving the Genetic Testing market?
Falling costs of testing, more demand for precision medicine and steady research spending by drug makers and labs are driving the genetic testing market.
Back to Catalogue

Related Medical Devices reports in Latin America

See all

Related on genomics and diagnostics and lab testing

See the topic